Meyka Pro banner
General Moly, Inc.

Stay Updated with the Latest General Moly, Inc. GMO.TO News in Real Time

Find GMO.TO news now at Meyka AI. Stay informed with the latest General Moly, Inc. stocks updates, including price news, market analysis, and expert insights.

GMO.TOTSX
Basic MaterialsOther Precious Metals
$0.04
$0.00(0.00%)
Canadian Market opens in 5h 59m
Brooklyn Democrats Rule Change Blocked as Reformers Win Court Victory on August 25
📅 in about 5 hours

Brooklyn Democrats Rule Change Blocked as Reformers Win Court Victory on August 25

Brooklyn Democratic Party chair Rodneyse Bichotte Hermelyn proposed expanding executive committee voting from 42 to over 68 members. Reformers and city officials oppose the move as an attempt to block newly elected district leaders from removing her.

Read more 12
Supreme Court Clears Trump’s Mail Ballot Order for Midterms on August 25
📅 in about 4 hours

Supreme Court Clears Trump’s Mail Ballot Order for Midterms on August 25

Supreme Court allows Trump administration to implement parts of executive order restricting mail voting for midterms. Democratic-led states plan new lawsuits and California proposes felony penalties for ballot interference.

Read more 12
49ers Owner Jed York Pleads No Contest to Misdemeanor Charges in Ohio
📅 19 minutes ago

49ers Owner Jed York Pleads No Contest to Misdemeanor Charges in Ohio

49ers owner Jed York pleaded no contest to misdemeanor charges after arrest in Ohio. He paid $1,150 in fines and was sentenced to one day in jail, already served. The NFL will review the matter under its personal conduct policy.

Read more 12
Greater Manchester NHS Trust Declares Critical Incident as 350 Staff Strike
📅 11 hours ago

Greater Manchester NHS Trust Declares Critical Incident as 350 Staff Strike

Greater Manchester NHS trust declares critical incident as 350 staff strike over overtime pay dispute with NHS Professionals agency on August 24, 26, and 28.

Read more 12
Australia Post Hires 3,500 Seasonal Workers; Truck Drivers Earn Up to $42.26/Hour
📅 11 hours ago

Australia Post Hires 3,500 Seasonal Workers; Truck Drivers Earn Up to $42.26/Hour

Australia Post opens 3,500 seasonal jobs for Christmas rush. Truck drivers earn $42.26/hour, parcel sorters $35.83/hour. Applications open now; roles start September and October.

Read more 12
Shein Targets $27B (£20B) Valuation in Long-Awaited Hong Kong IPO, Raising to $1.8B
📅 16 hours ago

Shein Targets $27B (£20B) Valuation in Long-Awaited Hong Kong IPO, Raising to $1.8B

Shein launched its Hong Kong IPO on Monday, August 24, 2026, targeting a valuation of up to 27billion.Thefast-fashionretaileraimstoraiseasmuchasHK13.86 billion, or 1.77billion.ShareswillpricebetweenHK47.60 and HK$49.50 apiece.  IPO Structure and Timeline Shein is selling 280 million Class B shares in the offering. The company will confirm its final IPO price on August 31, 2026. Trading on the Hong…

Read more 12
TVS Supply Chain Solutions Rallies 9% to ₹131 on Strategic MoU and Equity Stake by Japan’s Sankyu
📅 18 hours ago

TVS Supply Chain Solutions Rallies 9% to ₹131 on Strategic MoU and Equity Stake by Japan’s Sankyu

TVS Supply Chain Solutions witnessed strong buying momentum on August 24, 2026. Shares surged nearly 9% to trade around ₹131. Investors reacted positively to the strategic Memorandum of Understanding signed with Japan-based Sankyu Inc. Under this alliance, Sankyu plans to acquire a 0.5% equity stake in TVS Supply Chain Solutions.  The deal combines global engineering…

Read more 12
Trump White House Legislative Director James Braid Exits in September
📅 19 hours ago

Trump White House Legislative Director James Braid Exits in September

White House legislative affairs director James Braid is leaving his post in September. He led Trump’s legislative agenda through Congress, including major bills and Cabinet confirmations.

Read more 12
Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win
📅 1 day ago

Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win

Moderna and Merck’s personalized mRNA cancer vaccine succeeded in Phase 3 melanoma trials, reducing disease recurrence. MRNA jumped 8.9% and MRK rose 2.4% on the announcement.

Read more 12

GMO.TO News FAQ